Ajdarkosh, Hossein

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Chehrehgosha, H., Sohrabi, M. R., Ismail-Beigi, F., Malek, M., Reza Babaei, M., Zamani, F., Ajdarkosh, H., Khoonsari, M., Fallah, A. E., & Khamseh, M. E. (2021) · Diabetes Therapy

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 173

Body Roundness Index and Waist-to-Height Ratio are Strongly Associated With Non-Alcoholic Fatty Liver Disease: A Population-Based Study

Motamed, N., Rabiee, B., Hemasi, G. R., Ajdarkosh, H., Khonsari, M. R., Maadi, M., Keyvani, H., & Zamani, F. (2016) · Hepatitis Monthly

Liver Disease Diagnosis and TreatmentBody Composition Measurement Techniques

Cited by 80

Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial

Attaran, F., Emami, S., Sohrabi, M., Malek, M., Ajdarkosh, H., Khoonsari, M., Ismail-Beigi, F., & Khamseh, M. E. (2023) · BMC Gastroenterology

Cardiovascular Function and Risk FactorsDiabetes Treatment and Management

Cited by 22